CARDIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-12-12 躺着做梦

审稿速度:2.0
经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof

240 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2022-11-04 ms9000000158483950

投稿历时1个月14天，目前还在in review，建议催稿吗？

106 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2022-12-28 ms9000000158483950 来自浙江省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：临床研究;心血管疾病
经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。

108 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2022-11-16 ms9000000158483950

审稿速度:2.0
偏重的研究方向：临床研究;心血管疾病
经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2022-11-06 ms9000000158483950

偏重的研究方向：临床研究
经验分享：投稿1个半月，一直in review，没消息。要催一下么？

87 0

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2022-06-09 ms7000000930628341

请问大家在找回密码的时候有收不到邮件的问题吗

114 0

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-11-18 王海龙1

审稿速度:2.0 | 投稿命中率:5.0
经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?

116 0

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2018-10-30 ★眼大无神★

收不收费？这杂志luc-gradu 2018-03-06 发表::
祈祷luc-gradu 2018-03-06 00:00:00 发表:
祈祷

luc-gradu 2018-03-06 发表:: 祈祷

245 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2021-06-14 ms2000001529972856

7天无外审，被拒

151 0

[GetPortalCommentsPageByObjectIdResponse(id=907452, encodeId=d39e90e452e1, content=审稿速度:2.0 经验分享：10月中旬接收，到现在还没收到proof，奇怪的是，编辑说先Online再给我proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=501a5443902, createdName=躺着做梦, createdTime=Sat Dec 12 23:08:28 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098492, encodeId=7bd1209849222, content=投稿历时1个月14天，目前还在in review，建议催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Fri Nov 04 14:49:24 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107854, encodeId=3ccc210e85406, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：临床研究;心血管疾病 经验分享：今天接受了！历时3个月。 9月中旬投稿，12月下旬接受。期间一次大修。editor和reviewers都比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Dec 28 16:47:20 CST 2022, time=2022-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2100913, encodeId=6610210091360, content=审稿速度:2.0 偏重的研究方向：临床研究;心血管疾病 经验分享：投稿40多天，今天收到邮件给了大修，大修后拒稿概率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Wed Nov 16 17:22:58 CST 2022, time=2022-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098803, encodeId=37fe209880350, content=偏重的研究方向：临床研究 经验分享：投稿1个半月，一直in review，没消息。要催一下么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732d5415594, createdName=ms9000000158483950, createdTime=Sun Nov 06 10:51:04 CST 2022, time=2022-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225420, encodeId=a56e1225420fc, content=请问大家在找回密码的时候有收不到邮件的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38545502132, createdName=ms7000000930628341, createdTime=Thu Jun 09 12:42:18 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071246, encodeId=0efc10e1246ce, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投了两篇被拒，现在第三篇不知道怎么样呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211118/19d6eb66bb1f480b80853d15524c9384/cee1cb09d15443088b0c94e9466190ee.png, createdBy=7e102097748, createdName=王海龙1, createdTime=Thu Nov 18 00:46:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562521, encodeId=96c3562521fd, content=收不收费？这杂志luc-gradu 2018-03-06 发表:: 祈祷luc-gradu 2018-03-06 00:00:00 发表: 祈祷, beContent=luc-gradu 2018-03-06 发表:: 祈祷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/14be5eb1ed131be901374da80ac2448a.jpg, createdBy=4ec92402937, createdName=★眼大无神★, createdTime=Tue Oct 30 00:00:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973488, encodeId=468b9e34889f, content=7天无外审，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7275501885, createdName=ms2000001529972856, createdTime=Mon Jun 14 17:03:29 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591293, encodeId=6c2959129387, content=二审9天就接受了，按要求仔细修改问题就不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/020dfb7c19fe367cbd32599f56a21ee6.jpg, createdBy=db233855655, createdName=Vierhys, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=)]

2020-05-20 Vierhys

二审9天就接受了，按要求仔细修改问题就不大。

228 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务